PAHC Financials Phibro Animal Health Corp

15 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated Aug 30, 2026, 10:12 UTC Overview →

Growth & profitability

Revenue has grown 12.7% per year over the past 5 years.
Net income has grown in line with revenue (12.9% vs 12.7% per year).
Operating margin has expanded, at 12.8% in the latest year.
Free cash flow has declined 12.3% per year over the past 5 years.

Financial health

Total debt has grown faster than revenue (29.9% vs 12.7% per year).
Operating income covered interest expense 4.2× in the latest year.

Shareholder returns

Dividends have been paid for 7 consecutive years, consuming 19.5% of earnings and 197.3% of free cash flow.
The dividend has grown 0.0% per year over the past 5 years.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
2026	$1.5B	$100M	33.8%	12.8%	25.9%	6.6%	$10M	—	$61M
2025	$1.3B	$48M	30.9%	8.5%	16.9%	3.5%	$42M	$632M	$68M
2024	$1.0B	$2M	30.8%	5.2%	0.9%	0.2%	$46M	$312M	$71M
2023	$978M	$33M	30.5%	7.3%	11.5%	3.4%	-$38M	$334M	$41M
2022	$942M	$49M	30.3%	8.4%	18.7%	5.3%	-$5M	$288M	$74M
2021	$833M	$54M	32.6%	9.0%	22.8%	6.5%	$19M	—	$50M
2020	$800M	$34M	32.1%	8.6%	17.8%	4.3%	$25M	—	$36M
2019	—	$55M	—	—	25.3%	7.5%	$17M	—	$58M
2018	—	$65M	—	—	35.1%	9.7%	$51M	—	$29M
2017	—	$65M	—	—	42.7%	10.4%	$78M	—	$56M
2016	—	$83M	—	—	91.4%	13.6%	$866000	—	$34M
2015	—	$60M	—	—	203.5%	12.2%	—	—	$29M
2014	—	-$3M	—	—	-20.6%	-0.7%	—	$286M	$12M
2013	—	$25M	—	—	-36.1%	5.2%	—	$298M	$27M
2012	—	$7M	—	—	-7.9%	—	—	—	$54M

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
Jun '26	$397M	$22M	33.9%	12.1%	5.6%	1.4%	$5M	—	$61M
Mar '26	$384M	$24M	32.8%	11.6%	6.6%	1.7%	$890000	$621M	$55M
Dec '25	$374M	$27M	35.5%	13.5%	8.3%	2.0%	$8M	$624M	$55M
Sep '25	$364M	$27M	32.9%	14.1%	8.5%	1.9%	-$5M	$628M	$73M
Jun '25	$379M	$17M	29.0%	8.9%	6.0%	1.3%	$8M	$632M	$68M
Mar '25	$348M	$21M	30.1%	9.6%	7.8%	1.6%	$35M	$635M	$60M
Dec '24	$309M	$3M	32.9%	8.3%	1.3%	0.2%	-$5M	$639M	$67M
Sep '24	$260M	$7M	32.1%	6.8%	2.7%	0.7%	$3M	$295M	$52M
Jun '24	$273M	$752000	31.9%	6.7%	0.3%	0.1%	$15M	$312M	$71M
Mar '24	$263M	$8M	30.2%	7.6%	3.1%	0.9%	$2M	$321M	$50M
Dec '23	$250M	$1M	31.5%	6.3%	0.5%	0.1%	$21M	$324M	$33M
Sep '23	$231M	-$8M	29.3%	-0.3%	-2.9%	-0.8%	$9M	$329M	$43M
Jun '23	$255M	$11M	30.1%	9.3%	4.1%	1.2%	$9M	$334M	$41M
Mar '23	$246M	$10M	30.7%	7.6%	3.7%	1.0%	-$2M	$288M	$37M
Dec '22	$245M	$7M	31.6%	6.5%	2.7%	0.7%	-$12M	$292M	$68M
Sep '22	$233M	$4M	29.5%	5.9%	1.5%	0.4%	-$34M	$296M	$76M
Jun '22	$255M	$7M	30.7%	9.0%	2.9%	0.8%	-$10M	$288M	$74M
Mar '22	$240M	$18M	29.9%	8.0%	6.6%	1.9%	-$4M	—	$71M
Dec '21	$233M	$17M	30.4%	9.6%	7.3%	2.1%	$12M	—	$63M
Sep '21	$215M	$7M	30.1%	6.8%	2.8%	0.8%	-$4M	—	$41M

Valuation over time

How the market has priced PAHC against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has risen from 12.6× (Mar '23) to 15.8× (Nov '26).
The price-to-sales ratio has risen from 0.7× (Mar '23) to 1.0× (Nov '26).
The dividend yield has fallen from 3.1% (Mar '23) to 1.2% (Nov '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is PAHC growing its revenue and profit?

Over the past 5 years, Phibro Animal Health Corp's revenue has grown 12.7% per year, and net income grown 12.9% per year. These are computed facts, not advice.

How much debt does PAHC have?

As of FY2026, Phibro Animal Health Corp reported — of total debt against $61M of cash; operating income covered interest expense 4.2×.

What is PAHC's profit margin?

In FY2026, gross margin was 33.8%, operating margin 12.8%, and net margin 6.6%.

What is PAHC's P/E ratio?

Phibro Animal Health Corp's P/E (TTM) is 15.77 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the PAHC stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 15.8× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.